Skip to content

Patient Registry of Posner-Schlossman Syndrome

Patient Registry of Posner-Schlossman Syndrome

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800017580
Enrollment
Unknown
Registered
2018-08-04
Start date
2018-09-01
Completion date
Unknown
Last updated
2018-08-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Posner-Schlossman Syndrome

Interventions

Sponsors

Peking University Third Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
12 Years to 80 Years

Inclusion criteria

Inclusion criteria: Posner-Schlossman Syndrome Inclusion criteria: 1. Clinical diagnosis of Posner-Schlossman Syndrome; 2. Able to communicate with doctor and understand this study. Cataract Inclusion criteria: 1. Clinical diagnosis of age-related cataract; 2. Prepare for cataract operation; 3. Open angle and intraocular pressure is normally at anytime; 4. No family history of glaucoma. Primary open-angle glaucoma Inclusion criteria: 1. Both eyes involved; 2. Open angle; 3. Progressive glaucomatous optic neuropathy; 4. Specific visual field loss of glaucoma; 5. Intraocular pressure above the up limit of normal people.

Exclusion criteria

Exclusion criteria: Posner-Schlossman Syndrome Exclusion criteria: 1. Not be able to communicate with doctor and understand this study; 2. One or more authorized investigators think he or she will suffer from any severe risks from the study. Cataract Exclusion criteria: 1. Patients above 65 years old; 2. With Secondary ocular hypertension; 3. Have the history of receiving any ophthalmologic operation or anti-viral therapy; 4. With diabetes mellitus; 5. With autoimmune disease; 6. Be receiving any therapy that can influence the virus-infection state and biochemical characteristics of serum and aqueous humor, or have received such therapy before one month. POAG Exclusion criteria: 1. Patients above 65 years old; 2. With Secondary ocular hypertension; 3. Have the history of receiving any ophthalmologic operation or anti-viral therapy; 4. With diabetes mellitus; 5. With autoimmune disease; 6. Be receiving any therapy that can influence the virus-infection state and biochemical characteristics of serum and aqueous humor, or have received such therapy before one month.

Design outcomes

Primary

MeasureTime frame
cytokine;virus DNA;visual acuity;intraocular pressure;slit-lamp examination;

Secondary

MeasureTime frame
fundus photograph;OCT;visual field;psychological questionnaires;

Countries

China

Contacts

Public ContactChun Zhang

Peking University Third Hospital

zhangc1@yahoo.com+86 18601031059

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026